S102: LUSPATERCEPT VERSUS EPOETIN ALFA FOR TREATMENT (TX) OF ANEMIA IN ESA-NAIVE LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS (PTS) REQUIRING RBC TRANSFUSIONS: DATA FROM THE PHASE 3 COMMANDS STUDY

Detalles Bibliográficos
Autores principales: Della Porta, Matteo Giovanni, Platzbecker, Uwe, Santini, Valeria, Zeidan, Amer M., Fenaux, Pierre, Komrokji, Rami S., Shortt, Jake, Valcárcel, David, Jonášová, Anna, Dimicoli-Salazar, Sophie, Tiong, Ing Soo, Lin, Chien-Chin, LI, Jiahui, Zhang, Jennie, Carolina Giuseppi, Ana, Kreitz, Sandra, Pozharskaya, Veronika, Keeperman, Karen L., Rose, Shelonitda, Shetty, Jeevan K., Hayati, Sheida, Vodala, Sadanand, Degulys, Andrius, Paolini, Stefania, Cluzeau, Thomas, Garcia-Manero, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Plenary Abstracts Session
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428433/
http://dx.doi.org/10.1097/01.HS9.0000967316.99954.0c

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428433/
http://dx.doi.org/10.1097/01.HS9.0000967316.99954.0c

Ejemplares similares